Press release
Biosimilars Market Size Growing at 24.7% CAGR, Set to Reach USD 143.6 Bn By 2031 | Pfizer Inc., Novartis AG (Sandoz), Amgen Inc., Biocon Ltd.
Request Sample Copy of the Report:
https://www.alliedmarketresearch.com/request-sample/162
The biosimilars market has been experiencing significant growth in recent years. Biosimilars are highly similar versions of approved biologic drugs, offering comparable safety, efficacy, and quality to the reference products.
The primary driving factors behind the biosimilars market growth include the expiry of patents for several biologic drugs, increasing healthcare costs, and the need for affordable treatment options.
Biosimilars provide an opportunity for cost savings and improved access to essential therapies. They can potentially reduce healthcare expenditures by offering lower-priced alternatives to expensive biologics.
Regulatory frameworks have been established in various countries to ensure the safety and efficacy of biosimilars. These frameworks include stringent comparability studies and clinical trials to demonstrate biosimilarity to the reference product.
Major therapeutic areas targeted by biosimilars include oncology, autoimmune diseases, and inflammatory disorders. Biosimilars have been developed for popular biologic drugs like monoclonal antibodies, insulin, erythropoietin, and growth hormones.
Market Segmentation:
By Product Type: Biosimilar products can be categorized based on the type of biologic drug they are designed to replicate. This includes monoclonal antibodies, insulin, erythropoietin, growth hormones, and others.
By Therapeutic Area: Biosimilars are developed for specific therapeutic areas or diseases. Common therapeutic areas targeted by biosimilars include oncology, autoimmune diseases (such as rheumatoid arthritis and psoriasis), inflammatory disorders (such as Crohn's disease and ulcerative colitis), and supportive care (such as anemia and growth disorders).
By Geography: The biosimilars market can be segmented by geographical regions, such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Market dynamics and regulatory landscapes vary across regions, impacting the adoption and growth of biosimilars.
By Distribution Channel: Biosimilar products can be distributed through various channels, including hospital pharmacies, retail pharmacies, specialty pharmacies, and online pharmacies. The choice of distribution channel can vary based on the product and the healthcare system in a particular region.
Request for Customization -
https://www.alliedmarketresearch.com/request-for-customization/162
Competitive Landscape:
Pfizer Inc.
Novartis AG (Sandoz)
Amgen Inc.
Biocon Ltd.
Celltrion Inc.
Samsung Bioepis Co., Ltd.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Fresenius Kabi AG
Dr. Reddy's Laboratories Ltd.
Buy this Premium Research Report:
https://www.alliedmarketresearch.com/purchase-enquiry/162
VALUE PROPOSITIONS RELATED TO THE REPORT:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment.
Browse more latest healthcare reports:
Nerve Repair and Regeneration Market https://www.alliedmarketresearch.com/nerve-repair-and-regeneration-market
Ostomy Drainage Bags Market https://www.alliedmarketresearch.com/ostomy-drainage-bags-market
Computer-Aided Drug Discovery Market https://www.alliedmarketresearch.com/computer-aided-drug-discovery-market-A16823
Ambulatory X-Ray Devices Market https://www.alliedmarketresearch.com/ambulatory-x-ray-devices-market-A13405
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biosimilars Market Size Growing at 24.7% CAGR, Set to Reach USD 143.6 Bn By 2031 | Pfizer Inc., Novartis AG (Sandoz), Amgen Inc., Biocon Ltd. here
News-ID: 3080409 • Views: …
More Releases from Allied Market Research
Activewear Market is likely to expand US$ 771.8 billion at 6.2% CAGR by 2032
The activewear market size was valued at $425.5 billion in 2022, and is estimated to reach $771.8 billion by 2032, growing at a CAGR of 6.2% from 2023 to 2032.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/3249
Market Overview
Activewear is apparel, footwear, and accessories meant for sports and physical activities such as sprinting, yoga, bicycle riding, and other sports. Activewear comprises lightweight, breathable fabrics that allow for…
Sports Apparel Market Size To Exceed USD 410.8 billion By 2032 | CAGR of 6%
The sports apparel market size was valued at $230.60 billion in 2022, and is estimated to reach $410.8 billion by 2032, growing at a CAGR of 6% from 2023 to 2032.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/711
Sports apparel is mainly worn during workout sessions or while playing sports. It is designed to provide comfort and agility while performing physical movements. These apparels are made using breathable…
Luxury Travel Market Can Touch Approximately USD 2149.7 billion, Developing at a …
According to a new report published by Allied Market Research, titled, "Luxury Travel Market," The luxury travel market size was valued at $890.8 billion in 2023, and is estimated to reach $2149.7 billion by 2035, growing at a CAGR of 7.4% from 2024 to 2035.
Get Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/1662
Luxury travel refers to travel experiences that offer exceptional comfort, exclusivity, and personalized services, typically catering to…
Cleaning Services Market is poised to reach USD 111,498.8 million, growing at a …
The global cleaning services market size was valued at $55,715.0 million in 2020, and is projected to reach $111,498.8 million by 2030, registering a CAGR of 6.5% from 2021 to 2030. The floor care segment was the highest contributor to the market, with $12,293.8 million in 2020, and is estimated to reach $22,820.2 million by 2030, at a CAGR of 5.7% during the forecast period.
Request The Sample PDF…
More Releases for Biosimilar
Interchangeable Biosimilar Humira Market Share Driven by Biologic Therapy Adopti …
Interchangeable Biosimilar Humira Market
The global market for Interchangeable Biosimilar Humira was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-33I15005/Global_Interchangeable_Biosimilar_Humira_Market_Research_Report_2023
The Interchangeable Biosimilar Humira Market is experiencing significant market growth as healthcare providers and patients increasingly adopt biosimilar therapies for autoimmune and inflammatory conditions. Market trends indicate rising…
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Biosimilar Market Treating More for Less: The Booming Infliximab Biosimilar Mark …
Infliximab Biosimilar Market worth $ XX Million by 2030 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Infliximab Biosimilar Market- by Application (Crohn's Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis and Others), End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Direct Distribution Channels), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Get…
Biosimilar Monoclonal Antibodies Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Biosimilar Monoclonal Antibodies Market by Product (infliximab, trastuzumab, rituximab, adalimumab, bevacizumab, cetuximab, ranibizumab, denosumab, eculizumab, and other pipeline products), Indication (oncology, inflammatory & autoimmune disorders, chronic diseases, blood disorders, and other indications), Clinical Trial/Pipeline Analysis, Future Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
The Biosimilar Monoclonal Antibodies Market Size is valued at 5.02…
Infliximab Biosimilar Insight, 2022 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2022" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Interested to know more about the functioning of…
